Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Mark D Johnson Researcher Activity Profile

Research Author Detailed Information 

profile photo of Mark D JohnsonMark D johnson researcher

Mark D Johnson Publication Rate By Year

Mark D Johnson has published 1 paper(s) in 1971, 2 paper(s) in 1985, 1 paper(s) in 2001, 1 paper(s) in 2004, 1 paper(s) in 2005, 4 paper(s) in 2006, 27 paper(s) in 2007, 7 paper(s) in 2008, for a total of 44 research publications in total.

Mark D Md Johnson Author Information

LAST NAME: johnson

FIRST NAME: Mark D

INITIALS: md

AFFILIATION:

Papers

Mark D Johnson's Publication Record

  1. Drug-induced oxidative stress in rat liver from a toxicogenomics perspective. Year Published: 2005
  2. Johnson & Johnson Pharmaceutical Research and Development, LLC, Route 202, Box 300, Raritan, NJ 08869, USA.
  3. Influence of patient preference and primary care clinician proclivity for watchful waiting on receipt of depression treatment. Year Published: 2006
  4. Department of Psychiatry and Behavioral Sciences, University of Washington, P.O. Box 356560, Seattle, WA 98195, USA. mdjohnso@u.washington.edu <mdjohnso@u.washington.edu>
  5. A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Year Published: 2006
  6. Department of Neurological Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  7. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Year Published: 2006
  8. Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94270, USA. rmneve@lbl.gov
  9. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase. Year Published: 2006
  10. Laboratory of Medicinal Chemistry, NCI, NIH, Frederick, Maryland 21702, USA.
  11. Spatiotemporal pH dynamics following insertion of neural microelectrode arrays. Year Published: 2007
  12. Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
  13. Ion transport in alveolar type I cells. Year Published: 2007
  14. Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  15. Intrinsic electrical properties of spinal motoneurons vary with joint angle. Year Published: 2007
  16. Department of Physiology, 303 E. Chicago Avenue, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
  17. Adenosine regulation of alveolar fluid clearance. Year Published: 2007
  18. Pulmonary, Allergy, and Critical Care Medicine, Columbia University, 639 West 168th Street, New York, NY 10027, USA. phf2103@columbia.edu
  19. A probability-based spectroscopic diagnostic algorithm for simultaneous discrimination of brain tumor and tumor margins from normal brain tissue. Year Published: 2007
  20. Dept of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA. shovan.k.majumder@vanderbilt.edu
  21. MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research. Year Published: 2007
  22. Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical Center, 1150 West Medical Center Drive, Med Sci I, Room 5323, Ann Arbor, MI 48109-0612, USA. jimmyrae@umich.edu
  23. Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Year Published: 2007
  24. Department of Pediatrics, Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA.
  25. Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. Year Published: 2007
  26. Graduate Institute of Biochemistry, National Taiwan University, Taipei, Taiwan.
  27. Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor. Year Published: 2007
  28. Department of Medicinal Chemistry, Pfizer Global Research and Development, La Jolla, 10770 Science Center Dr., San Diego, CA 92121-1194, USA. min.teng@pfizer.com
  29. Neural interface dynamics following insertion of hydrous iridium oxide microelectrode arrays. Year Published: 2007
  30. Dept. of Biomed. Eng., Michigan Univ., Ann Arbor, MI.
  31. Optimization of microelectrode design for cortical recording based on thermal noise considerations. Year Published: 2007
  32. Dept. of Biomed. Eng., Cleveland Clinic Found., OH.
  33. Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors. Year Published: 2007
  34. Department of Medicinal Chemistry, Pfizer Global Research and Development, La Jolla, Inc., 10770 Science Center Drive, San Diego, California 92121-1194, USA. min.teng@biogenidec.com
  35. Zymogen activation, inhibition, and ectodomain shedding of matriptase. Year Published: 2007
  36. Department of Biochemistry and Molecular Biology, Greenborne Cancer Center, University of Maryland, School of Medicine, Baltimore, MD 21201, USA. cylin@som.umaryland
  37. Neuronal differentiation and expression of neural epitopes in pituitary adenomas. Year Published: 2007
  38. Dept. of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave., Box 626, Rochester, NY 14623. mahlon_johnson@urmc.rochester.edu.
  39. Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors. Year Published: 2007
  40. Department of Medicinal Chemistry, Pfizer Global Research and Development, La Jolla, Inc., 10770 Science Center Drive, San Diego, California 92121-1194, USA. min.teng@biogenidec.com
  41. New prospects for management and treatment of inoperable and recurrent skull base meningiomas. Year Published: 2007
  42. Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of Rochester Medical Center, 601 Elmwood Ave. Box 626, Rochester, NY, 14623, USA, mahlon_johnson@urmc.rochester.edu.
  43. Zymogen activation, inhibition, and ectodomain shedding of matriptase. Year Published: 2007
  44. Department of Biochemistry and Molecular Biology, Greenborne Cancer Center, University of Maryland, School of Medicine, Baltimore, MD 21201, USA. cylin@som.umaryland
  45. A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemia. Year Published: 2007
  46. Department of Pharmacy Practice, Campbell University School of Pharmacy, Buies Creek, NC, USA; Department of Pharmacy, Durham Veterans Affairs Medical Center, Durham, NC, USA.
  47. Neuronal differentiation and expression of neural epitopes in pituitary adenomas. Year Published: 2007
  48. Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave., Box 626, Rochester, NY 14623, USA. mahlon_johnson@urmc.rochester.edu
  49. Neuronal differentiation and expression of neural epitopes in pituitary adenomas. Year Published: 2007
  50. Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave., Box 626, Rochester, NY 14623, USA. mahlon_johnson@urmc.rochester.edu
  51. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1. Year Published: 2007
  52. Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
  53. A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Year Published: 2008
  54. Bioinformatigram, The University of of Michigan Medical Center, Ann Arbor, MI 48109 USA.
  55. Alveolar epithelial transport in the adult lung. Year Published: 2007
  56. Department of Medicine, University of California San Francisco, San Francisco, CA 94118, USA. leland.dobbs@ucsf.edu
  57. A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemia. Year Published: 2007
  58. Department of Pharmacy Practice, Campbell University School of Pharmacy, Buies Creek, NC, USA. townsend@mailcenter.campbell.edu
  59. Antibody response to E. coli urinary tract infection. Year Published: 1971
  60. A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Year Published: 2008
  61. Bioinformatigram, The University of of Michigan Medical Center, Ann Arbor, MI 48109 USA.
  62. New prospects for management and treatment of inoperable and recurrent skull base meningiomas. Year Published: 2007
  63. Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of Rochester Medical Center, 601 Elmwood Ave. Box 626, Rochester, NY 14623, USA. mahlon_johnson@urmc.rochester.edu
  64. Treatment of a juxtaglomerular tumour with radiofrequency ablation. Year Published: 2008
  65. Department of Radiology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  66. Treatment of a juxtaglomerular tumour with radiofrequency ablation. Year Published: 2008
  67. Department of Radiology, Vancouver General Hospital, Vancouver, British Columbia, Canada. alexkirkham@yahoo.com
  68. Neural interface dynamics following insertion of hydrous iridium oxide microelectrode arrays. Year Published: 2007
  69. Dept. of Biomed. Eng., Michigan Univ., Ann Arbor, MI 48109, USA. mdjzz@umich.edu
  70. Optimization of microelectrode design for cortical recording based on thermal noise considerations. Year Published: 2007
  71. Dept. of Biomed. Eng., Cleveland Clinic Found., OH 44195, USA. sfl5@case.edu
  72. Carcinoid tumor development in an intramedullary spinal cord mature teratoma. Year Published: 2001
  73. Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
  74. Erdheim-chester disease mimicking multiple meningiomas syndrome. Year Published: 2004
  75. Department of Pathology, Vanderbilt Medical School, Nashville, TN 37232, USA.
  76. Quinolinic acid stimulates luteinizing hormone secretion in female rats: evidence for involvement of N-methyl-D-aspartate-preferring receptors. Year Published: 1985
  77. Quinolinic acid stimulates luteinizing hormone secretion through a serotonin-dependent mechanism. Year Published: 1985
  78. Alveolar epithelial transport in the adult lung. Year Published: 2007
  79. Department of Medicine, University of California San Francisco, San Francisco, CA 94118, USA. leland.dobbs@ucsf.edu
  80. Treatment of a juxtaglomerular tumour with radiofrequency ablation. Year Published: 2008
  81. Department of Radiology, Vancouver General Hospital, Vancouver, British Columbia, Canada. alexkirkham@yahoo.com
  82. The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane x receptor. Year Published: 2008
  83. Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461. smani@montefiore.org.
  84. Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy, GFP imaging, and ultrasound. Year Published: 2008
  85. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA. mtt7@georgetown.edu
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News